Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Revenue (2022 - 2025)

Bioregenx (BRGX) has 4 years of Revenue data on record, last reported at $507755.0 in Q3 2025.

  • For Q3 2025, Revenue fell 14.81% year-over-year to $507755.0; the TTM value through Sep 2025 reached $1.9 million, down 24.56%, while the annual FY2024 figure was $2.3 million, 31.4% down from the prior year.
  • Revenue reached $507755.0 in Q3 2025 per BRGX's latest filing, up from $445969.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.1 million in Q1 2023 and bottomed at $3690.0 in Q3 2023.
  • Average Revenue over 4 years is $432747.1, with a median of $507755.0 recorded in 2025.
  • Peak YoY movement for Revenue: crashed 67.3% in 2023, then skyrocketed 16052.76% in 2024.
  • A 4-year view of Revenue shows it stood at $8914.0 in 2022, then soared by 7506.1% to $678008.0 in 2023, then crashed by 32.08% to $460489.0 in 2024, then grew by 10.26% to $507755.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $507755.0 in Q3 2025, $445969.0 in Q2 2025, and $515147.0 in Q1 2025.